Dimitris Moulavasilis is the Group Chief Executive Officer of M42, a global health champion powered by artificial intelligence (AI), technology and genomics to transform care for all. Consisting of over 480 clinics across 27 countries, and serving over 15 million patients annually, M42 delivers comprehensive healthcare services, including Renal Care, Outpatient and Chronic Disease Management, Diagnostics, Women's & Children's Health, Specialty Surgery, and Long-Term Care, as well as genomics and multi-omics, biobanking, environmental sciences, and population health programs, and AI and digital health solutions. Prior to M42, Dimitris served as the Chief Executive Officer of Diaverum, one of the world’s leading global renal care providers which was acquired by M42 in 2023, spearheading major digital transformation initiatives. Before this, he was the Group Chief Executive Officer at Affidea, a leading pan-European provider of imaging, outpatient and cancer care services. Earlier in his career, Dimitris held senior sales management roles at GE Healthcare. With over 30 years of healthcare experience, Dimitris is committed to leveraging AI and technology to democratize and revolutionize healthcare, ensuring high-quality, personalized care is accessible to all.